Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
$0.79
-2.3%
$0.76
$0.66
$3.09
$99.91M1.42159,714 shs27,464 shs
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$1.86
-0.8%
$1.68
$0.61
$5.77
$342.23M2.8911.35 million shs1.23 million shs
Quanterix Corporation stock logo
QTRX
Quanterix
$6.05
+2.5%
$5.72
$4.05
$16.74
$302.20M1.13608,700 shs122,558 shs
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$0.50
+0.8%
$0.54
$0.25
$1.40
$322.53M0.927.13 million shs558,231 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
+2.90%+3.82%+5.30%+9.93%-64.03%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
+3.31%-5.56%+9.36%+59.83%+103.53%
Quanterix Corporation stock logo
QTRX
Quanterix
-9.79%-14.74%+16.60%+22.66%-53.36%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-0.44%+0.61%-6.98%-13.66%+20.24%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
2.0617 of 5 stars
2.52.00.00.01.44.20.6
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
2.3356 of 5 stars
3.33.00.00.01.82.50.0
Quanterix Corporation stock logo
QTRX
Quanterix
2.4728 of 5 stars
3.21.00.00.02.63.30.6
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
1.5197 of 5 stars
3.81.00.00.01.10.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
1.00
Sell$2.13161.41% Upside
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
2.67
Moderate Buy$3.4885.83% Upside
Quanterix Corporation stock logo
QTRX
Quanterix
2.40
Hold$13.50128.81% Upside
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
3.50
Strong Buy$1.70244.83% Upside

Current Analyst Ratings Breakdown

Latest NAUT, QSI, QTRX, and SENS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/8/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$1.10 ➝ $1.40
6/2/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy$1.10
5/19/2025
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.50
5/16/2025
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
4/30/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/30/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$12.00 ➝ $8.00
4/10/2025
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$2.00
(Data available from 7/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/A$1.66 per shareN/A
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$3.06M112.14N/AN/A$1.29 per share1.45
Quanterix Corporation stock logo
QTRX
Quanterix
$137.42M2.14N/AN/A$8.57 per share0.69
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
$23.68M13.62N/AN/A$0.07 per share7.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$70.78M-$0.54N/AN/AN/AN/A-31.87%-27.39%7/29/2025 (Estimated)
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$101.01M-$0.68N/AN/AN/A-2,925.41%-41.44%-37.09%8/6/2025 (Estimated)
Quanterix Corporation stock logo
QTRX
Quanterix
-$38.53M-$1.30N/AN/AN/A-36.82%-15.07%-12.26%8/6/2025 (Estimated)
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/A

Latest NAUT, QSI, QTRX, and SENS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$0.16N/AN/AN/A$1.28 millionN/A
7/29/2025Q2 2025
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.14N/AN/AN/AN/AN/A
5/15/2025Q1 2025
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$0.17-$0.11+$0.06-$0.11$0.96 million$0.84 million
5/12/2025Q1 2025
Quanterix Corporation stock logo
QTRX
Quanterix
-$0.69-$0.53+$0.16-$0.53$28.27 million$30.33 million
4/29/2025Q1 2025
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
-$0.14-$0.13+$0.01-$0.13N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/AN/AN/AN/AN/A
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
N/AN/AN/AN/AN/A
Quanterix Corporation stock logo
QTRX
Quanterix
N/AN/AN/AN/AN/A
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
N/A
17.36
17.36
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
N/A
19.24
18.89
Quanterix Corporation stock logo
QTRX
Quanterix
N/A
8.29
7.53
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
59.17
2.47
2.38

Institutional Ownership

CompanyInstitutional Ownership
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
50.71%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
39.90%
Quanterix Corporation stock logo
QTRX
Quanterix
86.48%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
12.36%

Insider Ownership

CompanyInsider Ownership
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
41.10%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
30.04%
Quanterix Corporation stock logo
QTRX
Quanterix
6.90%
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
4.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nautilus Biotechnology, Inc. stock logo
NAUT
Nautilus Biotechnology
130126.15 million74.30 millionOptionable
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
150183.50 million128.38 millionOptionable
Quanterix Corporation stock logo
QTRX
Quanterix
46049.95 million46.51 millionOptionable
Senseonics Holdings, Inc. stock logo
SENS
Senseonics
90654.22 million573.90 millionN/A

Recent News About These Companies

Senseonics lays out hopes for next-gen CGM commercial timelines
Senseonics posts Q2 sales beat, submits 365-day CGM for CE mark

New MarketBeat Followers Over Time

Media Sentiment Over Time

Nautilus Biotechnology stock logo

Nautilus Biotechnology NASDAQ:NAUT

$0.79 -0.02 (-2.33%)
As of 10:41 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Quantum-Si stock logo

Quantum-Si NASDAQ:QSI

$1.86 -0.02 (-0.80%)
As of 10:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

Quanterix stock logo

Quanterix NASDAQ:QTRX

$6.05 +0.15 (+2.54%)
As of 10:41 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Senseonics stock logo

Senseonics NYSE:SENS

$0.50 +0.00 (+0.81%)
As of 10:42 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.